Concepedia

Alicia T. Widge

AT

18

Publications

3.8K

Citations

16

H-Index

2018

Active since

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Emory University

Leidos (United States)

Frederick National Laboratory for Cancer Research

Alicia T. Widge is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, vaccination, and immunology.

Top concepts

MedicineImmunologyVaccinationVirologyVaccine DevelopmentVaccine SafetyImmunotherapyViral ImmunityImmunodominanceHumoral Immunity

Publications per year

2018–2024

18

Publications

18

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Evan J. Anderson, Nadine Rouphael, Alicia T. Widge et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

Lingshu Wang, Tongqing Zhou, Yi Zhang et al. · Science · 2021 · 212 citations · Full text

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization

Nicole A. Doria‐Rose, Xiaoying Shen, Stephen D. Schmidt et al. · 2021 · 129 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +15

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 123 citations · Full text

Vaccination, Open-label Phase 1, Vaccine Target +10

Rows per page

1–5 of 18